Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

de Mulder M, Yebra G, Navas A, de José MI, Gurbindo MD, González-Tomé MI, Mellado MJ, Saavedra-Lozano J, Muñoz-Fernández MÁ, de Ory SJ, Ramos JT, Holguín A; Madrid Cohort of HIV-Infected Children..

PLoS One. 2012;7(12):e52155. doi: 10.1371/journal.pone.0052155.

2.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
3.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
4.

Delavirdine: a review of its use in HIV infection.

Scott LJ, Perry CM.

Drugs. 2000 Dec;60(6):1411-44. Review.

PMID:
11152019
5.

An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults.

Bartlett JA, Fath MJ, Demasi R, Hermes A, Quinn J, Mondou E, Rousseau F.

AIDS. 2006 Oct 24;20(16):2051-64. Review.

PMID:
17053351
6.

Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals.

Spaulding A, Rutherford GW, Siegfried N.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD008651. doi: 10.1002/14651858.CD008651. Review.

PMID:
20687097
7.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
8.
9.

Profile of darunavir in the treatment of HIV-infected pediatric and adolescent patients.

Dobroszycki J, Abadi J, Wiznia AA, Rosenberg MG.

Adolesc Health Med Ther. 2011 Sep 14;2:85-93. doi: 10.2147/AHMT.S11177. Review.

Items per page

Supplemental Content

Support Center